Antibody Responses 3-5 Months Post-Vaccination with mRNA-1273 or BNT163b2 in Nursing Home Residents

J Am Med Dir Assoc. 2021 Dec;22(12):2512-2514. doi: 10.1016/j.jamda.2021.10.001. Epub 2021 Nov 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273 / administration & dosage*
  • Aged
  • Aged, 80 and over
  • Antibody Formation*
  • BNT162 Vaccine / administration & dosage*
  • COVID-19 / prevention & control*
  • Female
  • Humans
  • Male
  • Nursing Homes
  • Ontario
  • Vaccination*

Substances

  • 2019-nCoV Vaccine mRNA-1273
  • BNT162 Vaccine